Loading
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Latest quote
$4.09
−$0.12 · -2.85%
After-hours
$4.09
$0.00 · 0.00%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Day range
Current $4.09
52-week range
Current $4.09
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
65
Undervalued
Sentiment
51
Mixed
Risk
80
High Risk
Momentum
26
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Day range
Current $4.09
52-week range
Current $4.09
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 119.48M USD | 113.69M USD | 130.38M USD | 115.38M USD | 102.6M USD |
| Cost of goods sold | 72.72M USD | 75.13M USD | 101.38M USD | 97.54M USD | 94.99M USD |
| Gross profit | 46.75M USD | 38.56M USD | 29M USD | 17.83M USD | 7.61M USD |
| Research and development | 21.24M USD | 38.4M USD | 57.31M USD | 48.86M USD | 36.74M USD |
| Selling, general, and administrative | 92.23M USD | 113.54M USD | 141.46M USD | 130M USD | 101.39M USD |
| Operating expenses | 113.46M USD | 151.94M USD | 198.77M USD | 178.85M USD | 138.13M USD |
| Interest income | 7.41M USD | 9.76M USD | 10.17M USD | 3.29M USD | 498K USD |
| Interest expense | 13.95M USD | 23.87M USD | 12.68M USD | 3.57M USD | 1.72M USD |
| Depreciation and amortization | 4.34M USD | 5.73M USD | 5.81M USD | 5.17M USD | 5.16M USD |
| Operating income | −66.71M USD | −113.38M USD | −169.77M USD | −161.02M USD | −130.52M USD |
| Net income | −81.65M USD | −127.98M USD | −172.8M USD | −162.96M USD | −131.94M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$14.00
242.30% upsidePrice history unavailable
High $34.00Average $14.00Low $6.00Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI2.11M0.00%2.3T USD0.03%$379.56-0.39%
Vanguard Extended Market ETFVXF788.98K0.00%95.4B USD0.05%$233.13-0.15%
iShares Micro-Cap ETFIWC231.2K0.02%1.32B USD0.60%$182.79-0.31%
Dimensional - US Small Cap ETFDFAS210.79K0.00%33.66B USD0.31%$78.10+0.23%
Fidelity Disruptive Medicine ETFFMED143.14K0.28%52.31M USD0.50%$30.5665-1.78%
Avantis U.S. Small Cap Equity ETFAVSC112.55K—3.04B USD0.25%$69.96+0.47%
Dimensional - US Core Equity 2 ETFDFAC102.43K0.00%88.28B USD0.21%$45.11-0.15%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM100K0.09%116.54M USD0.73%$15.90-0.44%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCDimensional - US Small Cap ETFDFASFidelity Disruptive Medicine ETFFMEDAvantis U.S. Small Cap Equity ETFAVSCDimensional - US Core Equity 2 ETFDFACEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
